Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiglucerase maintenance frequency study in adult type I Gaucher disease
NL-OMON21048Active, not recruiting
- Sponsor
- N/A
- Start
- May 2003
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of imiglucerase in Gaucher disease type 1 (GD1) (2 arms), sponsored by N/A. Primary endpoint: Change in liver ratio. Started May 2003; status: active, not recruiting.
02
Drugs
imiglucerase
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on NL-OMON21048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21048.